Home Cart Sign in  
Chemical Structure| 1026-05-7 Chemical Structure| 1026-05-7
Chemical Structure| 1026-05-7

*Storage: Keep in dark place,Inert atmosphere,Room temperature.

*Shipping: Normal

2-Methyl-N-phenyl-1,2,3,4-tetrahydroquinolin-4-amine

CAS No.: 1026-05-7

4.5 *For Research Use Only !

Cat. No.: A320127 Purity: 95%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
100mg łËͶÊÊ In Stock In Stock Login
250mg ł§ÿ¶ÊÊ In Stock In Stock Login
1g łÇÊó¶ÊÊ In Stock Inquiry Login
5g łÍîǶÊÊ Inquiry Inquiry Login

Please Login or Create an Account to: See VIP prices and availability

  • 100mg

    łËͶÊÊ

  • 250mg

    ł§ÿ¶ÊÊ

  • 1g

    łÇÊó¶ÊÊ

  • 5g

    łÍîǶÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 1026-05-7 ]

CAS No. :1026-05-7
Formula : C16H18N2
M.W : 238.33
SMILES Code : CC1NC2=C(C=CC=C2)C(NC3=CC=CC=C3)C1
MDL No. :MFCD00183927
Boiling Point : No data available
InChI Key :FTECJLOPKLYFII-UHFFFAOYSA-N
Pubchem ID :2839906

Safety of [ 1026-05-7 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Calculated chemistry of [ 1026-05-7 ] Show Less

Physicochemical Properties

Num. heavy atoms 18
Num. arom. heavy atoms 12
Fraction Csp3 0.25
Num. rotatable bonds 2
Num. H-bond acceptors 0.0
Num. H-bond donors 2.0
Molar Refractivity 79.98
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

24.06 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.63
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.98
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.96
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

3.06
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.84
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

3.09

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-4.19
Solubility 0.0155 mg/ml ; 0.0000651 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-4.19
Solubility 0.0155 mg/ml ; 0.0000651 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-5.78
Solubility 0.000396 mg/ml ; 0.00000166 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

Yes
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

Yes
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

Yes
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-4.93 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.86

Application In Synthesis [ 1026-05-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1026-05-7 ]
  • Downstream synthetic route of [ 1026-05-7 ]

[ 1026-05-7 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 15727-49-8 ]
  • [ 1026-05-7 ]
YieldReaction ConditionsOperation in experiment
82% With DPZ In chloroform; toluene at 25℃; for 15 h; Molecular sieve; Sealed tube; Irradiation; Green chemistry Will dissolve in 200μLOrganic photocatalyst DPZ in toluene (0.28 mg, 0.0008 mmol)Take a 10mL reaction flask,Dry the toluene with an air pump and add 66 mg (0.4 mmol)2-phenylaminopropionic acid and 100mg 4Å molecular sieves,Then add 4mL purified and dried chloroform and seal the bottle mouth with a rubber stopper.And insert a balloon filled with dry air. Place the reaction flask in a 25°C incubator.The reaction was stirred for 15 hours under the irradiation of two 1W blue LED lamps.After the reaction is complete, use a rotary evaporator to distill 2/3 of the solution.Separation by column chromatography (hexane/ethyl acetate 60-30:1)That is, 39.1 mg of 2-methyl-4-N-phenyl-tetrahydroquinolin-4-amine are obtained as a colorless oily liquid.The yield was 82percent.
References: [1] Patent: CN108017579, 2018, A, . Location in patent: Paragraph 0008; 0011; 0012.
  • 2
  • [ 75-07-0 ]
  • [ 62-53-3 ]
  • [ 1026-05-7 ]
References: [1] Patent: WO2004/72041, 2004, A1, . Location in patent: Page/Page column 79-80.
  • 3
  • [ 2028-84-4 ]
  • [ 75-07-0 ]
  • [ 62-53-3 ]
  • [ 1026-05-7 ]
  • [ 33863-77-3 ]
References: [1] Tetrahedron Letters, 1990, vol. 31, # 14, p. 2069 - 2072.
  • 4
  • [ 4346-59-2 ]
  • [ 75-07-0 ]
  • [ 62-53-3 ]
  • [ 1026-05-7 ]
  • [ 112825-69-1 ]
References: [1] Tetrahedron Letters, 1990, vol. 31, # 14, p. 2069 - 2072.
  • 5
  • [ 15727-49-8 ]
  • [ 3684-12-6 ]
  • [ 27356-66-7 ]
  • [ 1026-05-7 ]
References: [1] Advanced Synthesis and Catalysis, 2018, vol. 360, # 9, p. 1754 - 1760.
  • 6
  • [ 100-34-5 ]
  • [ 75-07-0 ]
  • [ 62-53-3 ]
  • [ 1026-05-7 ]
  • [ 779-54-4 ]
References: [1] Tetrahedron Letters, 1990, vol. 31, # 14, p. 2069 - 2072.
[2] Tetrahedron Letters, 1990, vol. 31, # 14, p. 2069 - 2072.
  • 7
  • [ 64-17-5 ]
  • [ 62-53-3 ]
  • [ 91-55-4 ]
  • [ 1026-05-7 ]
  • [ 32142-34-0 ]
  • [ 808758-69-2 ]
  • [ 1780-19-4 ]
References: [1] Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry, 2013, vol. 43, # 4, p. 500 - 508.
  • 8
  • [ 64-17-5 ]
  • [ 75-07-0 ]
  • [ 62-53-3 ]
  • [ 1026-05-7 ]
References: [1] Bulletin of the Chemical Society of Japan, 1969, vol. 42, p. 2885.
 

Related Products

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1026-05-7 ]

Aryls

Chemical Structure| 2061996-91-4

A223491 [2061996-91-4]

(R)-3-(Pyrrolidin-2-yl)aniline hydrochloride

Similarity: 0.81

Chemical Structure| 3469-20-3

A257957 [3469-20-3]

2,3-Diphenyl-1H-indole

Similarity: 0.80

Chemical Structure| 147769-93-5

A126026 [147769-93-5]

(S)-3-Methyl-1-(2-(piperidin-1-yl)phenyl)butan-1-amine

Similarity: 0.79

Chemical Structure| 17272-83-2

A160107 [17272-83-2]

N1-Benzylbenzene-1,4-diamine

Similarity: 0.74

Chemical Structure| 6855-64-7

A192984 [6855-64-7]

2-Phenyl-1H-indol-5-amine

Similarity: 0.73

Amines

Chemical Structure| 801156-77-4

A136989 [801156-77-4]

1,2,3,4-Tetrahydroquinolin-4-amine

Similarity: 0.98

Chemical Structure| 1416354-44-3

A104289 [1416354-44-3]

7-Methyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine dihydrochloride

Similarity: 0.88

Chemical Structure| 61894-99-3

A330985 [61894-99-3]

2,3,4,9-Tetrahydro-1H-carbazol-3-amine

Similarity: 0.86

Chemical Structure| 116650-33-0

A572442 [116650-33-0]

(R)-2,3,4,9-Tetrahydro-1H-carbazol-3-amine

Similarity: 0.86

Chemical Structure| 1263284-26-9

A139684 [1263284-26-9]

1,2,3,4-Tetrahydrocyclopenta[b]indol-2-amine

Similarity: 0.84

Related Parent Nucleus of
[ 1026-05-7 ]

Tetrahydroquinolines

Chemical Structure| 801156-77-4

A136989 [801156-77-4]

1,2,3,4-Tetrahydroquinolin-4-amine

Similarity: 0.98

Chemical Structure| 19343-79-4

A153032 [19343-79-4]

2,4-Dimethyl-1,2,3,4-tetrahydroquinoline

Similarity: 0.84

Chemical Structure| 1780-19-4

A295010 [1780-19-4]

1,2,3,4-Tetrahydroquinaldine

Similarity: 0.83

Chemical Structure| 52601-70-4

A163091 [52601-70-4]

8-Methyl-1,2,3,4-tetrahydroquinoline

Similarity: 0.83

Chemical Structure| 635-46-1

A107215 [635-46-1]

1,2,3,4-Tetrahydroquinoline

Similarity: 0.83